{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:19:23Z","timestamp":1787786363310,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mcna.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T13:01:37Z","timestamp":1742907697000},"page":"749-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Venous Thromboembolism Prevention in the Hospitalized Medical Patient"],"prefix":"10.1016","volume":"109","author":[{"given":"Nikolaos","family":"Tsaftaridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cholagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Spyropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.mcna.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.mcna.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ajh.20983","article-title":"Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism","volume":"82","author":"Anderson","year":"2007","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.mcna.2025.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","article-title":"The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs","volume":"137","author":"Grosse","year":"2016","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.mcna.2025.02.003_bib5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1378\/chest.07-0430","article-title":"Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis","volume":"132","author":"Piazza","year":"2007","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.mcna.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1538-7836.2004.01012.x","article-title":"The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry","volume":"2","author":"Monreal","year":"2004","journal-title":"J Thromb Haemostasis"},{"issue":"9","key":"10.1016\/j.mcna.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1160\/TH17-03-0168","article-title":"New paradigms in venous thromboprophylaxis of medically ill patients","volume":"117","author":"Spyropoulos","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mcna.2025.02.003_bib8","series-title":"StatPearls","article-title":"Prevention strategies","author":"Kisling","year":"2024"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/rth2.12021","article-title":"ISTH steering committee on world thrombosis day. Impact of world thrombosis day campaign","volume":"1","author":"Wendelboe","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0392-9590.23.05177-5","article-title":"Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence","volume":"43","author":"Nicolaides","year":"2024","journal-title":"Int Angiol"},{"issue":"06","key":"10.1016\/j.mcna.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1055\/s-0040-1710326","article-title":"Prevention of venous thromboembolism in hospitalized medically ill patients: a U.S. Perspective","volume":"120","author":"Spyropoulos","year":"2020","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.mcna.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.2019003603","article-title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","volume":"135","author":"Darzi","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.mcna.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mcna.2025.02.003_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jth.12515","article-title":"D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial","volume":"12","author":"Cohen","year":"2014","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.mcna.2025.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619880008","article-title":"Estimation of acutely ill medical patients at venous thromboembolism risk eligible for extended thromboprophylaxis using APEX criteria in US hospitals","volume":"25","author":"Martin","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.mcna.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"2 Suppl","key":"10.1016\/j.mcna.2025.02.003_bib18","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.mcna.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa041533","article-title":"Electronic alerts to prevent venous thromboembolism among hospitalized patients","volume":"352","author":"Kucher","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2025.02.003_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjmed.2011.06.004","article-title":"Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients","volume":"124","author":"Woller","year":"2011","journal-title":"Am J Med"},{"issue":"2 Suppl 5","key":"10.1016\/j.mcna.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0037-1963(01)90094-0","article-title":"Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease","volume":"38","author":"Caprini","year":"2001","journal-title":"Semin Hematol"},{"issue":"11","key":"10.1016\/j.mcna.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and associative models to identify hospitalized medical patients at risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1055\/s-0037-1603929","article-title":"The IMPROVEDD VTE risk score: incorporation of D-dimer into the IMPROVE score to improve venous thromboembolism risk stratification","volume":"1","author":"Gibson","year":"2017","journal-title":"TH Open"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11239-012-0780-0","article-title":"Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review","volume":"35","author":"Huang","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.mcna.2025.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.02.011","article-title":"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19","author":"Schulman","year":"2024","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.mcna.2025.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619886022","article-title":"Improved benefit risk profile of rivaroxaban in a subpopulation of the MAGELLAN study","volume":"25","author":"Spyropoulos","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.mcna.2025.02.003_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001152","article-title":"External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism (IMPROVE) for medical patients in a tertiary health system","volume":"3","author":"Rosenberg","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jth.12108","article-title":"Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments","volume":"11","author":"Vardi","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.mcna.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.thromres.2013.08.013","article-title":"Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population","volume":"132","author":"Mahan","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.mcna.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2017.08.005","article-title":"Identifying predictors for bleeding in hospitalized cancer patients: a cohort study","volume":"158","author":"Patell","year":"2017","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1160\/TH16-01-0003","article-title":"External validation of the IMPROVE bleeding risk assessment model in medical patients","volume":"116","author":"Rosenberg","year":"2016","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.mcna.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.mcna.2025.02.003_bib35","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200332","article-title":"Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients","volume":"2","author":"Mottier","year":"2023","journal-title":"NEJM Evidence"},{"issue":"7","key":"10.1016\/j.mcna.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"issue":"7537","key":"10.1016\/j.mcna.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mcna.2025.02.003_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019459","article-title":"Association between asymptomatic proximal deep vein thrombosis and mortality in acutely ill medical patients","volume":"10","author":"Raskob","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.mcna.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2025.02.003_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1076029613481105","article-title":"Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors","volume":"19","author":"Hull","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jhm.1002","article-title":"Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients","volume":"7","author":"Amin","year":"2012","journal-title":"J Hosp Med"},{"issue":"10","key":"10.1016\/j.mcna.2025.02.003_bib42","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jamainternmed.2014.3384","article-title":"Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study","volume":"174","author":"Flanders","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.mcna.2025.02.003_bib43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMoa1805090","article-title":"Rivaroxaban for thromboprophylaxis after hospitalization for medical illness","volume":"379","author":"Spyropoulos","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2025.02.003_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","article-title":"Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial","volume":"153","author":"Hull","year":"2010","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.mcna.2025.02.003_bib45","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","article-title":"Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients","volume":"365","author":"Goldhaber","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2025.02.003_bib46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.mcna.2025.02.003_bib47","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.jacc.2020.04.071","article-title":"Post-discharge prophylaxis with rivaroxaban reduces fatal and major thromboembolic events in medically ill patients","volume":"75","author":"Spyropoulos","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mcna.2025.02.003_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002797","article-title":"Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: a trial sequential and cumulative meta-analysis","volume":"16","author":"Bajaj","year":"2019","journal-title":"PLoS Med"},{"issue":"20","key":"10.1016\/j.mcna.2025.02.003_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026229","article-title":"Benefit\u2013risk assessment of rivaroxaban for extended thromboprophylaxis after hospitalization for medical illness","volume":"11","author":"Raskob","year":"2022","journal-title":"JAHA"},{"issue":"3","key":"10.1016\/j.mcna.2025.02.003_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/SLA.0b013e3181b5d61c","article-title":"Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis?: a systematic review of direct clinical comparisons","volume":"251","author":"Morris","year":"2010","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.mcna.2025.02.003_bib51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/STROKEAHA.111.680298","article-title":"The effect of graduated compression stockings on long-term outcomes after stroke","volume":"44","author":"Dennis","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.mcna.2025.02.003_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619850897","article-title":"Proportion of US hospitalized medically ill patients who may qualify for extended thromboprophylaxis","volume":"25","author":"Miao","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"10.1016\/j.mcna.2025.02.003_bib53","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/jcm13072133","article-title":"System-wide thromboprophylaxis interventions for hospitalized patients at risk of venous thromboembolism: focus on cross-platform clinical decision support","volume":"13","author":"Tsaftaridis","year":"2024","journal-title":"JCM"},{"issue":"8","key":"10.1016\/j.mcna.2025.02.003_bib54","article-title":"Universal EHRs clinical decision support for thromboprophylaxis in medical inpatients","volume":"2","author":"Spyropoulos","year":"2023","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"key":"10.1016\/j.mcna.2025.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.07.025","article-title":"Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post hoc analysis of the IMPROVE-DD cluster randomized trial","author":"Goldin","year":"2024","journal-title":"J Thromb Haemostasis"},{"issue":"01","key":"10.1016\/j.mcna.2025.02.003_bib56","doi-asserted-by":"crossref","first-page":"028","DOI":"10.1055\/a-1984-7021","article-title":"A review of FXIa inhibition as a novel target for anticoagulation","volume":"43","author":"Koulas","year":"2023","journal-title":"H\u00e4mostaseologie"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:11:17Z","timestamp":1749503477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0025712525000239"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.02.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous Thromboembolism Prevention in the Hospitalized Medical Patient","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}